AMENDMENT AGREEMENTAmendment Agreement • August 14th, 2014 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT AGREEMENT (the “Agreement”) is dated as of August 13, 2014, by and between Immune Pharmaceuticals Inc., a Delaware corporation with offices located at Cambridge Innovation Center, One Broadway, 14th Floor, Cambridge, MA 02142 (the “Company”), and the investor signatory hereto (the “Investor”).
